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Abstract 
Background. Teicoplanin and vancomycin are glycopeptide antibiotics currently in use 
for treatment of  multidrug-resistant bacterial infections. 
Scope and Approach. Severe undesirable effects, such as ototoxicity, nephrotoxicity and 
neutropenia have been reported for vancomycin and teicoplanin, which necessitates 
monitoring the concentration of  these two drugs in different biological samples. In 
order to obtain precise and accurate results, sensitive, reliable and fast methods are 
necessary. The main aim of  this mini review is to give a clear and concise overview 
of  the recently developed, validated, novel and improved methods for glycopeptide 
antibiotic analyses in various biological matrices. Also, the variability of  the matrices 
requires optimal and effective sample preparation procedures to be developed, and so 
these are discussed.
Key Findings and Conclusions. Different liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) methods have been described for quantitative determination of  
glycopeptide antibiotics in various biological matrices. It was shown that protein 
precipitation was a convenient method for sample preparation despite the high number 
of  novel sample preparation methods.
Key Words: Vancomycin, teicoplanin, biological samples, determination, LC-MS/MS
INTRODUCTION
Multidrug-resistant (MDR) bacterial infections have become one of  the most serious 
problems worldwide (Jyoti et.al, 2014). Glycopeptide antibiotics including vancomycin 
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and teicoplanin are the first-line antibiotics for treatment of  MDR infections (Jyoti 
et.al, 2014, Poonam Sood et al., 2010). These drugs are not effective against gram 
negative infections, and are currently in use for the treatment of  gram positive 
bacterial infections, especially those caused by methicillin-resistant S. aureus (MRSA) 
(Jyoti et.al, 2014). Their main mechanism of  action is inhibition of  the growth of  
susceptible organisms by interfering with cell-wall synthesis. Peptidoglycan synthesis 
is blocked by specific binding to D-alanyl-D-alanine residues (Kang & Park, 2015). 
Severe undesirable effects, such as ototoxicity, nephrotoxicity and neutropenia 
have been reported for vancomycin (Donald et al., 2006). Teicoplanin has a less 
toxic potential than vancomycin, but ototoxicity and nephrotoxicity have also been 
registered (Svetitsky et al., 2009). On the other hand, insufficient doses of  these two 
drugs could lead to antibiotic resistance and disease progression. In order to ensure 
sufficient levels for therapeutic efficacy and avoid toxic levels of  these two drugs, 
monitoring the drug concentrations is needed and highly recommended. 
According to the literature, different analytical methods have been reported for 
determination of  vancomycin and/or teicoplanin in various matrices. The main aim 
of  this review is to provide a detailed overview of  published methods for determining 
the concentration of  vancomycin and/or teicoplanin in different types of  samples in 
recent years, focusing on 2014-2017. Reviews were published in 2007, and 2015 dealing 
with the methods for vancomycin determination only and sample preparation (Vila et 
al., 2007; Javorska et. al., 2016). Although a recently published review covered the 
methods published by 2015 for vancomycin determination (Javorska et al., 2016), the 
current review gives a clear and concise overview of  the novel or improved methods, 
focusing on 2014-2017, for vancomycin and/or teicoplanin quantification in different 
matrices.
The main aim in developing any analytical method is achieving good selectivity, 
sensitivity and extraction efficiency, which requires an efficient sample preparation 
method. Removing matrix components is required in order to minimize or eliminate 
the matrix effect in liquid chromatography-tandem mass spectrometry (LC-MS/
MS) procedures, which have recently become more popular. Matrix components 
influence the ionization efficiency in the ionization source, reducing the sensitivity 
of  the method. Techniques commonly used for sample preparation include protein 
precipitation (PP), liquid-liquid extraction (LLE) solid-phase extraction (SPE), and in 
this review their application for sample treatment for the two glycopeptide antibiotics 
is presented (Javorska et al., 2017; Begou et al., 2017; Kim et al., 2016; Sheng & Zhou, 
2017; Brozmanová et al., 2017; Wicha & Kloft, 2016; Oyaert et al., 2015; Cao et al., 
2014; Cazorla-Reyes et al., 2014; Zhang, 2014a; Zhang et al., 2014b; Bijleveld et al., 
2014; Li et al., 2014). 
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Analytical methods
Protein precipitation. Protein precipitation is a simple, cost-effective, efficient, and time-
saving method which includes removing proteins from the sample by denaturing 
them with appropriate organic solvent or acid followed by centrifugation. Protein 
precipitation was the method of  choice for preparation of  samples containing 
vancomycin or teicoplanin (Javorska et al., 2017; Begou et al., 2017; Sheng & Zhou, 
2017; Brozmanová et al., 2017; Wicha & Kloft, 2016; Oyaert et al., 2015; Cao 
et al., 2014; Zhang et al., 2014b; Bijleveld et al., 2014; Cazorla-Reyes et al., 2014). 
Acetonitrile is frequently used as a precipitation agent for preparing plasma, serum, 
urine or peritoneal/pleural effusion containing vancomycin, and plasma or serum 
containing teicoplanin, giving a good extract purity (Oyaert et al., 2015; Cao et al., 
2014, Javorska et al., 2017; Cazorla-Reyes et al., 2014, Begou et al., 2017; Cazorla-Reyes 
et al., 2014). However, acetonitrile did not achieve sufficient recovery for vancomycin 
determination in plasma or serum (Cao et al., 2014; Cazorla-Reyes et al., 2014). On 
the other hand, high recovery was obtained for vancomycin determination in low 
volumes of  plasma, serum, urine or peritoneal/pleural effusion using acetonitrile as 
precipitation agent (Oyaert et al., 2015, Javorska et al., 2017). Namely, Begou et al 
(2017) investigated optimal deproteinization and extraction protocol from plasma 
in order to obtain high extraction recovery for all six teicoplanin components. Two 
different solvents (acetonitrile and methanol) in various volume ratios and using a 
low sample volume were tested. The highest recovery (more than 80%) was reached 
using ice-cold acetonitrile in a 3/1 (v/v) ratio. All other investigated combinations 
gave lower recoveries (Begou et al., 2017). Also, trichloroacetic acid can be applied 
as a precipitation agent for extraction of  vancomycin in plasma or serum (Sheng & 
Zhou, 2017; Bijleveld et al., 2014, Brozmanová et al., 2017). Poor extraction purity, 
and thus low recovery (65.6%), was achieved by applying 10% trichloroacetic acid for 
precipitation of  proteins from human plasma containing vancomycin (Bijleveld et al., 
2014). The application of  10% trichloroacetic acid in combination with acetonitrile 
resulted in much better extraction purity and high recovery (Sheng & Zhou, 2017). 
Serum samples were prepared using 33% trichloroacetic acid as a precipitation agent 
and 0.5 mol L-1 ammonium hydroxide in order to increase pH value (Brozmanová et 
al., 2017). Methanol as a protein precipitation agent was used for determination of  
vancomycin in human plasma, bone or fat tissue, where the extraction recovery was 
approximately 100%, and in bacterial growth medium (Zhang et al., 2014b; Wicha & 
Kloft, 2016). The main disadvantage of  protein precipitation as a sample preparation 
method is that matrix components other than proteins can remain in the sample, 
so it is of  great importance to find optimal precipitation agents, optimal values of  
centrifugation parameters, and sample:precipitation agent ratios.
Solid-phase extraction (SPE) Although the main advantage of  the SPE procedure is that 
can be automated, in the previous three years, this was not implemented for samples 
that contained vancomycin and/or teicoplanin. 
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Direct injection. Direct injection is a cost-effective and time-saving method. However, the 
main disadvantage for direct injection of  plasma samples is that conventional HPLC 
columns can be clogged by proteins such as albumin that can remain on the column. 
Recently, analytical columns have been designed to exclude proteins, so allowing 
smaller molecules to interact with the stationary phases. Direct injection was a method 
of  choice for plasma preparation in order to determine teicoplanin concentrations 
(Kim et al., 2016). Also, the dilution effect of  a buffer with various acidic additives, 
such as formic acid and ammonium formate, was determined. Dilution (10-fold) of  
plasma with deionized water containing 0.1% formic acid gave the desired sensitivity 
for the analysis of  all six components of  teicoplanin (Kim et al., 2016).
Ultrafiltration. This technique allows the separation of  free and protein-bound drug 
using ultrafiltration tubes that contain membrane with a molecular weight limit. 
Although therapeutic drug monitoring is based on total drug concentration in plasma 
or serum, for vancomycin, only that proportion which remains non-protein-bound 
is responsible for the antimicrobial activity. Zhang et al. (2014a) investigated the 
influence of  the total protein levels and plasma osmotic pressure on the volume ratio 
of  the ultrafiltrate to sample and on the free vancomycin level. In order to resolve this 
problem, hollow fiber centrifugal ultrafiltration was applied. This method could be 
successfully implemented in practice because of  the results that it could give. Its main 
disadvantage is complexity of  handling (Li et al., 2014; Zhang, 2014a).
Liquid-liquid extraction (LLQ). LLQ was often used in the past after protein precipitation 
for the analysis of  vancomycin. On the other hand, in recent years, LLQ has not been 
utilized for determination of  vancomycin and/or teicoplanin because of  the toxic 
solvents that were used and the difficulty of  automation (Cao et al., 2014).
Sample types, volumes and preparation methods for determining vancomycin and/or 
teicoplanin published mainly in the last three years are summarized in Table 1.
The coupling of  LC with the excellent sensitivity and specificity of  MS is a combination 
that allows more definitive identifications, and quantitative determinations of  
compounds that are not fully resolved chromatographically.
Different suitable C18 stationary phases are selected taking into account the nature 
of  the investigated substances. High sensitivity and short analysis time is allowed by 
using an ultra performance liquid chromatography (UPLC) column for determination 
of  vancomycin and simultaneous determination of  teicoplanin and vancomycin 
(Brozmanová et al., 2017, Cazorla-Reyes et al., 2014). Special attention was paid to 
a UPLC-HILIC (hydrophilic interaction liquid chromatography) column that was 
utilized for vancomycin determination. HILIC mode, because of  its high polarity and 
hydrophilicity, is especially convenient for vancomycin determination (Oyaert et al., 
2015). Also, the high content of  organic solvent, which is required for HILIC mode, 
is of  great importance for MS detection in order to achieve better sensitivity. An 
overview of  the columns utilized is given in Table 1. 
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For determination of  vancomycin and teicoplanin, isocratic or gradient elution modes 
have been applied (Zhang et al., 2014a, Javorska et al., 2017; Begou et al., 2017; 
Sheng & Zhou, 2017; Brozmanová et al., 2017; Kim et al., 2016; Wicha & Kloft, 
2016; Oyaert et al., 2015; Cao et al., 2014; Zhang et al., 2014b; Bijleveld et al., 2014; 
Li et al., 2014; Cazorla-Reyes et al., 2014). In isocratic mode, phosphate buffer was 
mixed with acetonitrile for the analysis of  vancomycin, and analysis time was 10 
min (Zhang et al., 2014a). In recent years, isocratic elution mode has not been the 
preferred elution method, as gradient elution more successfully eliminates endogenous 
compounds from samples containing vancomycin or teicoplanin, and so has become 
much more common. The gradient elution mode allows the use of  a high content 
of  organic solvent that is more suitable for MS detection. The most frequently used 
organic solvent in gradient mode for quantitative determination of  vancomycin and/
or teicoplanin is acetonitrile, but some authors reported use of  methanol for analysis 
of  these two drugs (Javorska et al., 2017; Begou et al., 2017; Sheng & Zhou, 2017; 
Brozmanová et al.; 2017; Kim et al., 2016; Wicha & Kloft, 2016; Oyaert et al., 2015; 
Cao et al., 2014; Bijleveld et al., 2014; Li et al., 2014; Zhang, 2014aZhang et al., 2014b; 
Cazorla-Reyes et al., 2014). In most cases, the aqueous phase consisted of  water with 
different contents of  formic acid (0.01-0.1%) (Javorska et al., 2017; Begou et al., 2017; 
Kim et al., 2016; Wicha & Kloft, 2016; Oyaert et al., 2015; Cazorla-Reyes et al., 2014; 
Zhang et al., 2014a; Zhang et al., 2014b; Li et al., 2014;). Also, it was reported that 
the aqueous phase could contain phosphate and ammonium acetate buffer (Cao et 
al., 2014; Sheng & Zhou, 2017; Brozmanová et al., 2017; Bijleveld et al., 2014; Li et 
al., 2014). Different gradient elution programs were implemented with various ratios 
of  organic solvent to aqueous phase. The mobile phase compositions and types of  
elution mode are presented in Table 1.
According to literature published in the last three years, there are no published methods 
for analysis of  teicoplanin that utilize UV detection. In the case of  vancomycin 
analysis, there are three studies dealing with the LC method that used UV detection 
detection, UV detection is less sensitive and selective, so (Cao et al., 2014; Li et al., 
2014; Zhang, 2014a). The detection wavelength was between 230 nm and 282 nm. 
However, compared with MS most methods for vancomycin and/or teicoplanin 
determination utilize MS detection.
Nowadays, LC-MS/MS is the method of  choice for the analysis of  vancomycin and all 
six components of  teicoplanin in biological matrices. Vancomycin and teicoplanin are 
polypeptide structures, so the positive electrospray ionization (ESI) mode was selected 
in all recently published studies. For most polar compounds of  high molecular weights, 
ESI is the first choice (Kazakevich, 2007). Large molecules with several ionizable sites, 
including teicoplanin and vancomycin, produce multiply-charged ions by ESI. All of  
the six components of  teicoplanin and vancomycin were ionized as doubly charged 
molecular ions [M+2H] 2+ (Tsai et al., 2013). Teicoplanin A2-2/A2-3 (isomers 1) and 
teicoplanin A2-4/A2-5 (isomers 2) are isomer pairs with the same fragmentation, mass 
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spectrometry parameter values, and chromatographic behavior and in the analysis 
were detected as two peaks.
Considering the previously mentioned facts about the mobile phase composition, in all 
published studies regarding vancomycin and teicoplanin determination, the addition 
of  formic acid in the mobile phase and in samples preparation were described in order 
to achieve the desired protonation and good ionization efficiency.
The use of  an internal standard is desirable to improve precision and accuracy. For MS 
methods, it is possible to use an isotopically labeled compound as an internal standard 
(Hoffmann, 2007). For vancomycin determination, vancomycin-des-leucine was used 
as an internal standard (Oyaert et al., 2015). Although isotopically-labeled internal 
standards are commercially available, high prices limit their use. The internal standards 
used in the previous three years for LC-MS/MS method development for vancomycin 
and/or teicoplanin determination are given in Table 1.
Also, among the published studies, a cost-effective system of  two-dimensional 
liquid chromatography with ultraviolet detection (2D-LC-UV) for measurement of  
vancomycin in human plasma was reported. This method combines the automation of  
immunoassay with the high selectivity and sensitivity of  LC coupled with MS detection 
(Sheng & Zhou, 2017; Li et al., 2014). 
CONCLUSION
In this mini-review, sample preparation procedures and chromatographic methods 
for determination of  vancomycin and/or teicoplanin are briefly presented with the 
emphasis on advantages and disadvantages of  their properties. In the last three years, 
protein precipitation has become the most frequently used method for preparation 
of  samples that contain vancomycin, teicoplanin or both. In order to reduce sample 
preparation time, there are efforts to automate sample preparation and to directly 
inject extracted sample into the LC-MS/MS system. Different LC–MS/MS methods 
have been described for quantitative determination of  vancomycin and/or teicoplanin 
in various matrices. LC-MS/MS techniques are increasingly widely applied in clinical 
practice for measurement of  these two drugs.
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PREGLED ANALITIČKIH METODA ZA ODREĐIVANJE 
VANKOMICINA I TEIKOPLANINA U BIOLOŠKOM 
MATERIJALU
STAJIĆ Ana, JANČIĆ-STOJANOVIĆ Biljana
Kratak sadržaj
Uvod. Teikoplanin i vankomicin su antibiotici glikopeptidne strukture koji se trenutno 
koriste u terapiji multirezistentnih bakterijskih infekcija.
Cilj i pristup. Ozbiljni neželjeni efekti vankomicina i teikoplanina kao što su ototoksičnost, 
nefrotoksičnost i neutropenija zahtevaju njihovo praćenje u različitim tipovima 
biološkog materijala. Osetljiva, pouzdana i brza metoda potrebna je u cilju dobijanja 
tačnih i preciznih podataka o koncentraciji pomenutih jedinjenja. Cilj ovog pregleda je 
da da jasan i kratak prikaz o razvijenim i validiranim novim, ili unapređenim metodama 
za analizu glikopeptidnih antibiotika u različitim biološkim matriksima. Takođe, u radu 
su opisane i metode pripreme uzorka upravo zbog raznovrsnosti biološkog materijala.
Ključni nalazi i zaključak. Opisane su raznovrsne LC-MS/MS metode za određivanje 
glikopeptidnih antibiotika u biološkom materijalu. Primećeno je da je precipitacija 
proteina pogodna metoda pripreme uzorka bez obzira na broj novijih metoda pripreme 
koje se koriste.
Ključne reči: Vankomicin, teikoplanin, uzorci biološkog materijala, određivanje, 
LC-MS/MS 
